Skip to content
IvaCaterina’s Waymakers

SPG4 and the heart: coincidence or clue? What two cardiologists say

A commentary published alongside the first case of SPG4 with dilated cardiomyopathy discusses what is known, what is not, and when a heart check might be worthwhile.

Author
Echipa editorialăThe association
Category
Research
Published
2 min read
Illustration: a small child's hand resting in an adult's palm, with teal nerve fibres and a DNA helix on a navy background.

AI-generated illustrative image. It does not depict real people, patients or partners.

A plain-language summary of a published scientific study. It is educational and does not replace medical advice.

The study: Panjrath G, Dakhakhni M, JACC: Case Reports, 12 August 2026. An editorial comment (the authors' opinion). Free full text.

What the commentary is about

The same journal described the first known case of a person with SPG4 who also developed dilated cardiomyopathy, a condition in which the heart enlarges and pumps more weakly. Two cardiologists discuss whether the two are linked or simply occurred together.

The arguments they make

  • A precedent. Friedreich ataxia was considered a purely neurological disease until it was found to affect the heart too; guidelines now require heart check-ups for these patients.
  • Little data in HSP. An earlier report described two people with hereditary spastic paraplegia and cardiomyopathy of unknown cause, but no larger studies followed.
  • Clues from the lab. In animals, switching off the SPAST gene increased the risk of stress-induced arrhythmias without changing the heart's structure or function. Transport of connexin 43, a protein that helps electrical signals pass between heart cells, was also affected.
  • It is not known whether people with SPAST variants are more vulnerable to such problems.

What it means for families

  • There are no official recommendations yet for heart check-ups in SPG4.
  • The authors suggest that neurologists also ask about heart symptoms and consider an electrocardiogram (ECG), a cheap and widely available test.
  • If symptoms such as breathlessness on exertion appear, the authors recommend a timely cardiology consultation.

What the study does not tell us yet

This is an opinion piece, not a study. A single case cannot prove a causal link, and heart involvement in SPG4 has not been established. Nor do the authors recommend SPAST testing for people with dilated cardiomyopathy.

References

  1. 1.

    Panjrath G, Dakhakhni M (2026). SPG4-Associated Hereditary Spastic Paraplegia and Dilated Cardiomyopathy: Coincidence or Clue?. JACC: Case Reports 31(32):109565 (editorial comment).

    PMID 42593014Last verified: 7 November 2026

    Commentary: there are no cardiac screening recommendations for SPG4 yet.

  2. 2.

    Gude S, Kleiven Ø, Edvardsen T (2026). Dilated Cardiomyopathy in a Woman With SPG4-Associated Hereditary Spastic Paraplegia. JACC: Case Reports 31(32):108746.

    PMID 42233908Last verified: 7 November 2026

    First reported case of SPG4 together with dilated cardiomyopathy; a causal link is not proven.

Further sources

Share this article

All news
Fluorescence-microscopy-style illustration of neurons in shades of teal and blue.

Research

Where SPG4 research stands in November 2026

An overview of the strategies being studied in the laboratory, the clinical studies that are registered (and those still missing) and the limits of the evidence so far.